The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Epidemiology | Fear, Phobias, and Panic | Obsessive-Compulsive Disorder | Hoarding Disorder | PTSD and Acute Stress Disorder | Anxiety in Comorbid Medical Illness | Anxiety and Late-Life Depression | Neurobiological and Neuropsychological Findings | Anxiety and Related Disorders in the Context of Neurocognitive Impairment | Assessment Instruments for Anxiety in Older Adults | Treatment of Late-Life Anxiety Disorders | Conclusion | References

Excerpt

Developments in clinical neuroscience have resulted in a rapid expansion in how brain disorders are understood. Included in this seemingly exponential growth in knowledge is a deepening insight into the biology and clinical phenotypes inherent to late-life neuropsychiatric syndromes. This chapter explores a subset of these syndromes: anxiety, obsessive-compulsive, and trauma-related disorders in older adults. Important to highlight in the beginning is a shift in how these three entities are now conceptualized, which is in part due to advances in basic and translational neuroscience. With the publication of DSM-5 (American Psychiatric Association 2013), trauma-related and obsessive-compulsive disorders were given their own respective sections, acknowledging that, although all three most assuredly contain some facet of anxious symptomatology, several key features warrant their being separated. Doing so allows for more valid diagnostic constructs, lessens heterogeneity in clinical research, and is more in line with neuronal network dysfunction corresponding to illness presentations. By characterizing the relevant epidemiology, biological underpinnings, clinical phenomenology, and evidence-based treatments, this chapter summarizes the current state of the field.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).